-
SkinSmart Antimicrobial debuts with eczema and wound care offerings
MINNEAPOLIS — SkinSmart Antimicrobial is a new skincare brand launching over-the-counter solutions for eczema and wound care. SkinSmart is powered by hypochlorous, an ingredient that has been used in specialty wound care for years to help heal chronic skin conditions, wounds and burns. Previously this formula was only available with a prescription, the company reported.
-
FDA approves first-ever gene therapy treatment for acute lymphoblastic leukemia
SILVER SPRING, Md. — The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.
The FDA approved Novartis' Kymriah (tisagenlecleucel) for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia. Kymriah is the first therapy based on gene transfer approved by the FDA.